Robb Gary Charles

Avg. Two Year Performance

29% Avg. Purchase Return
14% Compound
(4%) Avg. Sale Return
(2%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return23%37%102%79%29%
Purchase Success Rate1 of 11 of 11 of 11 of 11 of 1
Average Sale Return4%5%5%(4%)(4%)
Sale Success Rate2 of 42 of 41 of 41 of 40 of 4
Drugs » Biotechnology

Chief Financial Officer:

Holdings: 80.2K shares

Sentiment

Insider Trading Sentiment: Sell

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($240.22K) Net Amount
Buy:0--
Sell:($240.22K)$24.02